Two L&H workflows sit in the same lesson because they share the structural constraint that defines them - HIPAA-bounded operating environments where AI assistance requires Business Associate Agreements, where medical-information disclosure outside authorization is a breach event, and where the documentation chain serves both the underwriting/claim file and the litigation-defense file. The COLI/BOLI workflow covers corporate-owned life insurance and bank-owned life insurance on a key-person, executive-bonus, or supplemental-executive-retirement-plan (SERP)-funding case: IRC §101(j) Notice and Consent compliance, insurable-interest documentation, and the underwriting narrative AI drafts against the corporate purchaser's financials and the proposed insured executive's profile. The group LTD claim workflow covers disability-claim management at the 24-month policy pivot - the structural moment when a "own-occupation" disability standard transitions to "any-occupation," when functional-capacity evaluations (FCE), AMA Guides 6th Edition impairment ratings, and treating-physician statements determine continued benefit eligibility, when AI compresses the medical-records review under HIPAA, and when ERISA §503 claim-procedure compliance plus the Mental Health Parity and Addiction Equity Act (MHPAEA) non-quantitative-treatment-limitation (NQTL) check on behavioral-health overlays determine the legal defensibility of an adverse decision. This lesson walks both workflows with the structural constraints, the AI-assisted artifacts, and the cross-functional sign-off discipline that survives a regulatory examination and the eventual claim or coverage dispute that follows.

COLI/BOLI: The Policy Structure and the Tax Frame

Corporate-owned life insurance (COLI) is permanent life insurance on the lives of executives, key employees, or owner-managers where the corporation is policyowner, premium-payer, and beneficiary; the corporation uses the policy's tax-deferred cash-value buildup and tax-free death benefit to fund nonqualified deferred-compensation plans, supplemental executive retirement plans (SERP), key-person risk, executive-bonus arrangements, or general corporate purposes. Bank-owned life insurance (BOLI) is the same structure where the policyowner is a bank, typically used to offset employee-benefit costs and as a tax-advantaged asset on the bank's balance sheet. The U.S. COLI market exceeds $200B in face amount across mid-size to large enterprises; the BOLI market exceeds $185B in cash surrender value at U.S. banks per FDIC reporting.

The tax frame rests on IRC §101(j) - enacted in the Pension Protection Act of 2006 - which conditions the tax-free death benefit of an employer-owned life-insurance contract on satisfying Notice and Consent requirements. The corporation must, before issuance: (1) notify the employee in writing that the employer intends to insure the employee's life and the maximum face amount; (2) notify the employee in writing that the employer will be the beneficiary; (3) obtain the employee's written consent to be insured; (4) obtain the employee's written consent that coverage may continue after employment ends if the employer so chooses. Failure to satisfy §101(j) Notice and Consent disqualifies the death benefit from tax-free treatment - the entire benefit becomes taxable to the corporation at ordinary income rates. The single-largest tax-defect risk in COLI/BOLI underwriting is §101(j) noncompliance discovered on death claim adjudication years after issuance.

COLI/BOLI Underwriting Workflow: The AI-Assisted Narrative

The COLI/BOLI underwriting workflow has three documentation anchors: (1) IRC §101(j) Notice and Consent verification with signed copies in the file; (2) insurable-interest documentation establishing the corporation's interest in the proposed insured's life under applicable state law (typically the proposed insured is a director, officer, highly-compensated employee, or 5%+ shareholder; some states require additional documentation for cases approaching the boundary); (3) the underwriting narrative drafted against the corporate purchaser's financials (purpose of insurance, source of premium, expected use of death benefit), the proposed insured's role (key-person rationale, SERP-funding rationale, executive-bonus rationale), and the medical-underwriting evidence (typical for the insured's age, face amount, and product class).

AI compresses the narrative drafting. The structured prompt input: corporate-purchaser identification (name, EIN, industry, financial summary including balance sheet, income statement, key ratios); the proposed insured executive's role and compensation summary; the purpose statement (key-person / SERP / executive-bonus / general corporate); the projected use of cash value and death benefit; the §101(j) Notice and Consent execution chain (notice mailed, consent signed, all in carrier-approved templates with dated signatures). The structured output: an underwriting narrative addressing each documentation anchor with carrier-specific language, citing the relevant filed COLI/BOLI underwriting guidelines, supporting the actuarial decision with documented financial-underwriting analysis (does the proposed face amount align with insurable-interest economics, does the corporation's financial capacity support the premium payment over the expected horizon).

Insurable-Interest State-Law Considerations

State law governs insurable interest at the state of issuance or state of insured's residence depending on each state's choice-of-law rules. Most states have statutory frameworks codifying employer's insurable interest in employees including directors, officers, highly-compensated employees, and shareholders above defined thresholds. The Texas Insurance Code §1103 (Insurable Interest in Stranger-Owned Life Insurance), New York Insurance Law §3205 (Insurable Interest), California Insurance Code §10110.1 (Insurable Interest in Life Insurance), and similar statutes in other states create the operational framework. For COLI/BOLI on senior executives at large companies, the insurable interest is rarely contested; for COLI on owner-managers of mid-size businesses or for BOLI on highly-compensated bank employees, the documentation is more carefully scrutinized.

The AI-assisted insurable-interest analysis structures the documentation: the proposed insured's role (verified through corporate records - board minutes, employment agreements, organizational charts); the applicable state statutory framework citation; the carrier's filed underwriting-guideline criteria for insurable-interest satisfaction; the actuarial analysis supporting that the proposed face amount aligns with the documented interest (key-person cases typically support face amounts of 5-10× annual compensation or proven economic-value calculations; SERP-funding cases support face amounts consistent with projected SERP-liability accruals; executive-bonus cases support face amounts the executive could reasonably purchase on the executive's own life). The actuarial-financial-underwriting analysis closes the loop between the legal insurable-interest documentation and the economic rationality of the policy structure.

COLI/BOLI Medical Underwriting and FCRA

The medical underwriting for COLI/BOLI follows traditional individual-underwriting protocols - paramed, APS for material conditions, LexisNexis MVR, MIB, Rx feeds - adapted for the corporate-owner structure. The proposed insured executive provides medical authorization separately from the corporate purchaser. The medical-underwriting workflow surfaces the same triage decisions as personal-life cases (Ch7-L2 on MIB-Rx triage applies); the eventual class decision determines premium structure and policy economics for the corporate purchaser. FCRA §615 adverse-action notice obligations attach to the proposed insured executive personally for any decline or class-adjustment-with-adverse-action; the corporate purchaser receives separate notification about the underwriting outcome's impact on the proposed policy structure.

The proposed insured executive's FCRA §615 rights operate identically to personal-life cases: identification of CRAs, 60-day free-file-disclosure rights, dispute rights. The corporate purchaser is not a §615 subject (the consumer-protection framework attaches to the natural person); the corporate-purchaser communication addresses policy economics and structural alternatives (different face amount, different product, different proposed insured) without consumer-rights language. The dual-track communication - adverse-action notice to executive plus structural-alternatives memo to corporate purchaser - characterizes mature COLI/BOLI underwriting operations.

Group LTD Claim AI: The 24-Month Policy Pivot

Group long-term disability (LTD) insurance pays monthly benefit (typically 60% of pre-disability income to a maximum) when an employee covered under an employer-sponsored group LTD plan becomes disabled per the policy's disability definition. The structural moment in nearly all group LTD policies is the 24-month policy pivot: for the first 24 months of disability benefits, the disability definition is typically "own occupation" - the insured is disabled if unable to perform the material and substantial duties of the insured's own occupation; after 24 months, the definition typically transitions to "any occupation" - the insured is disabled only if unable to perform any occupation for which the insured is reasonably qualified by education, training, or experience. The transition disqualifies a meaningful percentage of insureds whose impairment limits own-occupation function but does not prevent any-occupation function.

The carrier's group LTD claim operations team at month-22 of an active claim begins the any-occupation transition assessment. The assessment uses: (1) updated treating-physician statements; (2) functional-capacity evaluation (FCE) if not recently performed; (3) labor-market analysis identifying occupations the insured could perform given documented functional capacity, education, training, and experience; (4) vocational evaluation if needed; (5) medical-records review of treating-physician records covering the prior 24 months. The carrier's decision at month-24: continue benefits under any-occupation standard; terminate benefits with documented rationale; offer settlement; or extend additional review time (with continued benefits pending) for incomplete evidence. AI compresses the medical-records review, structures the FCE summary, generates the labor-market-analysis input, and drafts the transition memo; the claim adjuster's professional judgment and the medical-director's clinical review own the eventual decision.

HIPAA-Bounded Medical-Records Review

Group LTD claim files routinely include hundreds to thousands of pages of medical records - treating-physician chart notes, specialist consultations, surgical reports, imaging studies, physical therapy notes, FCE reports, IME (independent medical examination) reports, AME (agreed medical examiner) reports where the workers-comp framework overlaps. Manual review consumed 8-24 adjuster-hours per 600-1,000 page record set; AI-assisted summarization compresses this to 1-3 hours of review-and-verification on the AI-extracted structured summary.

The HIPAA-bounded operating environment requirement: all AI processing of PHI must occur within a HIPAA-eligible environment with a signed Business Associate Agreement between the carrier and the AI provider. Acceptable 2026 environments: Azure OpenAI Service with executed BAA, AWS Bedrock with executed BAA, on-premise LLM deployment within the carrier's HIPAA-compliant network, GCP Vertex AI with executed BAA, or carrier-built LLM deployment. Unacceptable environments: consumer-grade ChatGPT, consumer Claude.ai, consumer Gemini, or any AI service without HIPAA-eligible enterprise tier and signed BAA. The discipline is non-negotiable: PHI processed in non-HIPAA-eligible environments constitutes an unauthorized disclosure under HIPAA §164.502 and triggers breach-notification obligations under HIPAA §164.404 plus state-specific data-breach notification laws.

The AI-assisted medical-records summary structures the file: (1) chronological treatment timeline with provider, date, and clinical content; (2) current diagnosis list with ICD-10 codes; (3) procedure history with CPT codes; (4) medication list with dosages and indication; (5) AME/IME opinions separated from treating-physician opinions (the distinction matters for weight in claim decisions); (6) AMA Guides 6th Edition impairment rating drivers if applicable; (7) FCE results summary if applicable; (8) treating-physician's prognosis statements verbatim; (9) any return-to-work potential discussion. The summary is the adjuster's review document; the underlying records remain in the file for verification and litigation purposes.

ERISA §503 Claim-Procedure Compliance

Group LTD plans are ERISA-governed employee-welfare plans; ERISA §503 establishes claim-procedure requirements including: (1) written notice of adverse benefit determination including specific reasons, references to plan provisions, description of additional information needed, and explanation of internal review procedures; (2) 45-day initial decision timeline with one 30-day extension if needed and timely notified; (3) full and fair review on appeal including consideration of all information submitted; (4) 45-day appeal-decision timeline with one 45-day extension if needed and timely notified; (5) right to receive copies of all documents in the claim file on request; (6) right to bring civil action under ERISA §502(a) after exhausting administrative remedies. The adverse-determination notice must be specific enough to enable an informed appeal; vague or boilerplate notices that fail this standard expose the carrier to ERISA §502(a) litigation where courts can apply de novo review rather than the more carrier-favorable arbitrary-and-capricious standard.

The any-occupation transition denial letter - drafted under §503 - addresses: the plan provision governing the transition; the specific medical, functional-capacity, and vocational evidence supporting the determination; the labor-market analysis identifying suitable occupations; the explanation of why the insured can perform those occupations given documented capacity; the procedure for internal review with timing; the right to receive claim-file documents; the right to subsequent civil action. AI drafts against the carrier's filed letter template; the claim adjuster, claim manager, and medical director review and sign. Defects in §503 notices are litigation exposure; the discipline is structural.

MHPAEA NQTL Check on Behavioral-Health Overlay

The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) requires group health and disability plans to apply non-quantitative treatment limitations (NQTLs) on mental-health and substance-use-disorder claims comparably to NQTLs on medical and surgical claims. NQTLs include: medical-necessity standards, prior-authorization requirements, fail-first protocols, network adequacy, formulary design, and claim-decision criteria. For group LTD, the NQTL parity check applies to any-occupation determinations involving behavioral-health components (depression, anxiety, PTSD, substance-use disorders) versus medical-only impairments. The carrier must demonstrate that the any-occupation determination methodology applies behavioral-health and medical impairments comparably; differential treatment (more aggressive scrutiny of behavioral-health claims, more onerous documentation requirements, narrower FCE criteria) is a parity violation.

The 2026 Department of Labor and Internal Revenue Service joint MHPAEA enforcement initiative has increased scrutiny on group LTD parity compliance. Carrier audits in 2024-2026 have produced material fines and corrective-action plans on plans with documented parity defects. The AI-assisted MHPAEA NQTL check on a behavioral-health-overlay LTD claim: documents the methodology applied; compares to methodology applied on comparable medical-only claims in the same period; identifies any disparate treatment; supports remediation if disparate treatment is found. The discipline aligns with broader MHPAEA compliance frameworks that the carrier's compliance team operates on the group health and disability portfolio. The cross-functional documentation includes the claim adjuster's analysis, the medical director's clinical review, and the compliance officer's MHPAEA-parity attestation.

Cross-Functional Sign-Off and Litigation-Defense Readiness

Both workflows produce documentation that serves underwriting/claim files and litigation-defense files. COLI/BOLI on death claim - plaintiff counsel (often the estate, the insured's family, or in some cases the corporate purchaser if a dispute emerges between policyowner and beneficiary intent) attacks the §101(j) Notice and Consent execution, the insurable-interest documentation, and the underwriting-narrative defensibility. Group LTD on transition denial - plaintiff counsel (the disability claimant) attacks the §503 notice specificity, the medical-evidence interpretation, the FCE methodology, the labor-market-analysis adequacy, and the MHPAEA NQTL parity if behavioral-health is in scope.

The carrier's litigation-defense posture rests on the documentation chain at underwriting or initial claim decision. Clean documentation produces clean defense; gap-ridden documentation produces settlement pressure regardless of substantive case strength. AI compresses documentation production at scale; the cross-functional sign-off - underwriter, medical director, compliance officer on COLI/BOLI; claim adjuster, claim manager, medical director, compliance officer on group LTD - attests to the personal review and judgment that NAIC §4 and the broader insurance-regulatory frameworks expect. The 2026 mature carrier operates both workflows with disciplined cross-functional sign-off; the rest face latent litigation exposure that surfaces unpredictably across years.

Key Takeaways

• COLI (corporate-owned life insurance) and BOLI (bank-owned life insurance) on key-person, SERP, executive-bonus, or general-corporate-purpose cases require IRC §101(j) Notice and Consent compliance; failure disqualifies tax-free death benefit treatment and exposes the entire benefit to ordinary income tax. U.S. COLI face amount exceeds $200B; BOLI cash surrender value exceeds $185B per FDIC reporting.
• Three COLI/BOLI underwriting documentation anchors: §101(j) Notice and Consent verification with signed copies; insurable-interest documentation per applicable state law (Texas Insurance Code §1103, NY Insurance Law §3205, CA Insurance Code §10110.1); underwriting narrative against corporate purchaser financials, proposed insured executive role, and medical-underwriting evidence.
• FCRA §615 adverse-action notice attaches to the proposed insured executive personally on any decline or class-adjustment-with-adverse-action; the corporate purchaser receives separate structural-alternatives memo without consumer-rights language. Dual-track communication characterizes mature COLI/BOLI operations.
• Group LTD's 24-month policy pivot transitions disability definition from "own occupation" to "any occupation"; transition disqualifies insureds whose impairment limits own-occupation function but does not prevent any-occupation function. Carrier assessment at month-22 includes updated treating-physician statements, FCE, labor-market analysis, vocational evaluation if needed, medical-records review.
• HIPAA-bounded operating environment is non-negotiable for AI processing of PHI: Azure OpenAI with BAA, AWS Bedrock with BAA, on-premise LLM, GCP Vertex AI with BAA, or carrier-built deployment. Consumer-grade ChatGPT / Claude.ai / Gemini are unacceptable; PHI in non-HIPAA-eligible environments triggers HIPAA §164.502 unauthorized-disclosure and §164.404 breach-notification.
• AI-assisted medical-records summary structures: chronological timeline; ICD-10 diagnosis list; CPT procedure history; medication list; AME/IME-vs-treating-physician opinion separation; AMA Guides 6th Edition impairment-rating drivers; FCE summary; treating-physician prognosis; return-to-work discussion. 8-24 adjuster-hours per 600-1,000 page set compresses to 1-3 hours of review-and-verification.
• ERISA §503 claim-procedure compliance on adverse benefit determination requires specific written notice with plan-provision references, evidence-specific reasoning, internal review procedures, 45-day initial-decision timeline with 30-day extension, 45-day appeal-decision timeline with 45-day extension, document-access rights, and §502(a) civil-action notice. Vague notices expose carrier to de novo judicial review.
• MHPAEA NQTL parity check on behavioral-health-overlay LTD claims compares methodology applied to behavioral health vs. medical-only claims; differential treatment is parity violation; 2024-2026 DOL/IRS joint enforcement initiative has produced material fines and corrective-action plans on documented defects.
• Cross-functional sign-off: COLI/BOLI requires underwriter, medical director, compliance officer; group LTD requires claim adjuster, claim manager, medical director, compliance officer. Clean documentation chain at underwriting or initial claim decision is the litigation-defense backbone for death claims (COLI/BOLI) and transition denial appeals (group LTD).